OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 26.25
-0.50 (-1.87%)
At close: Dec 5, 2025
OBI Pharma Revenue
OBI Pharma had revenue of 10.52M TWD in the quarter ending September 30, 2025, a decrease of -54.21%. This brings the company's revenue in the last twelve months to 49.29M, down -29.13% year-over-year. In the year 2024, OBI Pharma had annual revenue of 62.68M with 50.85% growth.
Revenue (ttm)
49.29M
Revenue Growth
-29.13%
P/S Ratio
140.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.68M | 21.13M | 50.85% |
| Dec 31, 2023 | 41.55M | 36.84M | 781.96% |
| Dec 31, 2022 | 4.71M | -14.06M | -74.90% |
| Dec 31, 2021 | 18.77M | -122.11M | -86.68% |
| Dec 31, 2020 | 140.89M | 135.30M | 2,422.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| EirGenix | 936.18M |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |